nodes	percent_of_prediction	percent_of_DWPC	metapath
Cevimeline—CYP3A4—Temozolomide—melanoma	0.158	0.385	CbGbCtD
Cevimeline—CYP2D6—Vemurafenib—melanoma	0.136	0.332	CbGbCtD
Cevimeline—CYP3A4—Vemurafenib—melanoma	0.0864	0.211	CbGbCtD
Cevimeline—CYP3A4—Docetaxel—melanoma	0.0297	0.0724	CbGbCtD
Cevimeline—Pruritus—Vemurafenib—melanoma	0.000631	0.00125	CcSEcCtD
Cevimeline—Urethral disorder—Temozolomide—melanoma	0.000628	0.00125	CcSEcCtD
Cevimeline—Alopecia—Dactinomycin—melanoma	0.000626	0.00124	CcSEcCtD
Cevimeline—Eye disorder—Carmustine—melanoma	0.00062	0.00123	CcSEcCtD
Cevimeline—Hyponatraemia—Docetaxel—melanoma	0.000619	0.00123	CcSEcCtD
Cevimeline—Visual impairment—Temozolomide—melanoma	0.000618	0.00123	CcSEcCtD
Cevimeline—Gastrointestinal haemorrhage—Docetaxel—melanoma	0.000616	0.00122	CcSEcCtD
Cevimeline—Pain in extremity—Docetaxel—melanoma	0.000616	0.00122	CcSEcCtD
Cevimeline—Flushing—Carmustine—melanoma	0.000616	0.00122	CcSEcCtD
Cevimeline—Ill-defined disorder—Bleomycin—melanoma	0.000614	0.00122	CcSEcCtD
Cevimeline—Anaemia—Bleomycin—melanoma	0.000611	0.00122	CcSEcCtD
Cevimeline—Diarrhoea—Vemurafenib—melanoma	0.00061	0.00121	CcSEcCtD
Cevimeline—Migraine—Docetaxel—melanoma	0.000607	0.00121	CcSEcCtD
Cevimeline—Eye disorder—Temozolomide—melanoma	0.000599	0.00119	CcSEcCtD
Cevimeline—Tinnitus—Temozolomide—melanoma	0.000598	0.00119	CcSEcCtD
Cevimeline—Malaise—Bleomycin—melanoma	0.000597	0.00119	CcSEcCtD
Cevimeline—Flushing—Temozolomide—melanoma	0.000595	0.00118	CcSEcCtD
Cevimeline—Cardiac disorder—Temozolomide—melanoma	0.000595	0.00118	CcSEcCtD
Cevimeline—Arrhythmia—Carmustine—melanoma	0.000593	0.00118	CcSEcCtD
Cevimeline—Leukopenia—Bleomycin—melanoma	0.000592	0.00118	CcSEcCtD
Cevimeline—Dizziness—Vemurafenib—melanoma	0.000589	0.00117	CcSEcCtD
Cevimeline—Alopecia—Carmustine—melanoma	0.000586	0.00116	CcSEcCtD
Cevimeline—Angiopathy—Temozolomide—melanoma	0.000582	0.00116	CcSEcCtD
Cevimeline—Malnutrition—Carmustine—melanoma	0.000578	0.00115	CcSEcCtD
Cevimeline—Cough—Bleomycin—melanoma	0.000577	0.00115	CcSEcCtD
Cevimeline—Chills—Temozolomide—melanoma	0.000575	0.00114	CcSEcCtD
Cevimeline—Dehydration—Docetaxel—melanoma	0.000573	0.00114	CcSEcCtD
Cevimeline—Ill-defined disorder—Dactinomycin—melanoma	0.000573	0.00114	CcSEcCtD
Cevimeline—Anaemia—Dactinomycin—melanoma	0.00057	0.00113	CcSEcCtD
Cevimeline—Vomiting—Vemurafenib—melanoma	0.000567	0.00113	CcSEcCtD
Cevimeline—Alopecia—Temozolomide—melanoma	0.000567	0.00113	CcSEcCtD
Cevimeline—Dry skin—Docetaxel—melanoma	0.000565	0.00112	CcSEcCtD
Cevimeline—Chest pain—Bleomycin—melanoma	0.000563	0.00112	CcSEcCtD
Cevimeline—Myalgia—Bleomycin—melanoma	0.000563	0.00112	CcSEcCtD
Cevimeline—Orthostatic hypotension—Docetaxel—melanoma	0.000563	0.00112	CcSEcCtD
Cevimeline—Rash—Vemurafenib—melanoma	0.000562	0.00112	CcSEcCtD
Cevimeline—Dermatitis—Vemurafenib—melanoma	0.000561	0.00112	CcSEcCtD
Cevimeline—Back pain—Carmustine—melanoma	0.000559	0.00111	CcSEcCtD
Cevimeline—Headache—Vemurafenib—melanoma	0.000558	0.00111	CcSEcCtD
Cevimeline—Malnutrition—Temozolomide—melanoma	0.000558	0.00111	CcSEcCtD
Cevimeline—Discomfort—Bleomycin—melanoma	0.000557	0.00111	CcSEcCtD
Cevimeline—Malaise—Dactinomycin—melanoma	0.000556	0.00111	CcSEcCtD
Cevimeline—Leukopenia—Dactinomycin—melanoma	0.000552	0.0011	CcSEcCtD
Cevimeline—Dysgeusia—Temozolomide—melanoma	0.000547	0.00109	CcSEcCtD
Cevimeline—Confusional state—Bleomycin—melanoma	0.000544	0.00108	CcSEcCtD
Cevimeline—Alanine aminotransferase increased—Docetaxel—melanoma	0.000544	0.00108	CcSEcCtD
Cevimeline—Tremor—Carmustine—melanoma	0.000541	0.00108	CcSEcCtD
Cevimeline—Oedema—Bleomycin—melanoma	0.00054	0.00107	CcSEcCtD
Cevimeline—Back pain—Temozolomide—melanoma	0.00054	0.00107	CcSEcCtD
Cevimeline—Infection—Bleomycin—melanoma	0.000536	0.00107	CcSEcCtD
Cevimeline—Anaemia—Carmustine—melanoma	0.000534	0.00106	CcSEcCtD
Cevimeline—Dysphagia—Docetaxel—melanoma	0.000533	0.00106	CcSEcCtD
Cevimeline—Agitation—Carmustine—melanoma	0.000531	0.00105	CcSEcCtD
Cevimeline—Nausea—Vemurafenib—melanoma	0.000529	0.00105	CcSEcCtD
Cevimeline—Thrombocytopenia—Bleomycin—melanoma	0.000529	0.00105	CcSEcCtD
Cevimeline—Myalgia—Dactinomycin—melanoma	0.000525	0.00104	CcSEcCtD
Cevimeline—Bronchospasm—Docetaxel—melanoma	0.000524	0.00104	CcSEcCtD
Cevimeline—Tremor—Temozolomide—melanoma	0.000523	0.00104	CcSEcCtD
Cevimeline—Discomfort—Dactinomycin—melanoma	0.000519	0.00103	CcSEcCtD
Cevimeline—Angina pectoris—Docetaxel—melanoma	0.000519	0.00103	CcSEcCtD
Cevimeline—Ill-defined disorder—Temozolomide—melanoma	0.000518	0.00103	CcSEcCtD
Cevimeline—Leukopenia—Carmustine—melanoma	0.000517	0.00103	CcSEcCtD
Cevimeline—Anaemia—Temozolomide—melanoma	0.000516	0.00102	CcSEcCtD
Cevimeline—Anorexia—Bleomycin—melanoma	0.000515	0.00102	CcSEcCtD
Cevimeline—Agitation—Temozolomide—melanoma	0.000513	0.00102	CcSEcCtD
Cevimeline—Hypotension—Bleomycin—melanoma	0.000505	0.001	CcSEcCtD
Cevimeline—Oedema—Dactinomycin—melanoma	0.000504	0.001	CcSEcCtD
Cevimeline—Malaise—Temozolomide—melanoma	0.000503	0.001	CcSEcCtD
Cevimeline—Vertigo—Temozolomide—melanoma	0.000501	0.000996	CcSEcCtD
Cevimeline—Convulsion—Carmustine—melanoma	0.0005	0.000994	CcSEcCtD
Cevimeline—Infection—Dactinomycin—melanoma	0.0005	0.000994	CcSEcCtD
Cevimeline—Leukopenia—Temozolomide—melanoma	0.0005	0.000993	CcSEcCtD
Cevimeline—Hypertension—Carmustine—melanoma	0.000499	0.000991	CcSEcCtD
Cevimeline—Palpitations—Temozolomide—melanoma	0.000493	0.00098	CcSEcCtD
Cevimeline—Thrombocytopenia—Dactinomycin—melanoma	0.000493	0.00098	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Bleomycin—melanoma	0.000492	0.000977	CcSEcCtD
Cevimeline—Chest pain—Carmustine—melanoma	0.000492	0.000977	CcSEcCtD
Cevimeline—Myalgia—Carmustine—melanoma	0.000492	0.000977	CcSEcCtD
Cevimeline—Anxiety—Carmustine—melanoma	0.00049	0.000974	CcSEcCtD
Cevimeline—Cough—Temozolomide—melanoma	0.000487	0.000968	CcSEcCtD
Cevimeline—Paraesthesia—Bleomycin—melanoma	0.000485	0.000963	CcSEcCtD
Cevimeline—Weight increased—Docetaxel—melanoma	0.000485	0.000963	CcSEcCtD
Cevimeline—Convulsion—Temozolomide—melanoma	0.000484	0.000961	CcSEcCtD
Cevimeline—Weight decreased—Docetaxel—melanoma	0.000482	0.000958	CcSEcCtD
Cevimeline—Hypertension—Temozolomide—melanoma	0.000482	0.000957	CcSEcCtD
Cevimeline—Dyspnoea—Bleomycin—melanoma	0.000481	0.000957	CcSEcCtD
Cevimeline—Anorexia—Dactinomycin—melanoma	0.00048	0.000954	CcSEcCtD
Cevimeline—Pneumonia—Docetaxel—melanoma	0.000478	0.000949	CcSEcCtD
Cevimeline—Confusional state—Carmustine—melanoma	0.000475	0.000944	CcSEcCtD
Cevimeline—Myalgia—Temozolomide—melanoma	0.000475	0.000944	CcSEcCtD
Cevimeline—Arthralgia—Temozolomide—melanoma	0.000475	0.000944	CcSEcCtD
Cevimeline—Anxiety—Temozolomide—melanoma	0.000473	0.000941	CcSEcCtD
Cevimeline—Oedema—Carmustine—melanoma	0.000471	0.000937	CcSEcCtD
Cevimeline—Discomfort—Temozolomide—melanoma	0.000469	0.000933	CcSEcCtD
Cevimeline—Decreased appetite—Bleomycin—melanoma	0.000469	0.000933	CcSEcCtD
Cevimeline—Infection—Carmustine—melanoma	0.000468	0.00093	CcSEcCtD
Cevimeline—Acute coronary syndrome—Docetaxel—melanoma	0.000468	0.00093	CcSEcCtD
Cevimeline—Myocardial infarction—Docetaxel—melanoma	0.000466	0.000925	CcSEcCtD
Cevimeline—Neuropathy peripheral—Docetaxel—melanoma	0.000466	0.000925	CcSEcCtD
Cevimeline—Stomatitis—Docetaxel—melanoma	0.000463	0.00092	CcSEcCtD
Cevimeline—Pain—Bleomycin—melanoma	0.000462	0.000917	CcSEcCtD
Cevimeline—Conjunctivitis—Docetaxel—melanoma	0.000462	0.000917	CcSEcCtD
Cevimeline—Thrombocytopenia—Carmustine—melanoma	0.000461	0.000917	CcSEcCtD
Cevimeline—Tachycardia—Carmustine—melanoma	0.00046	0.000914	CcSEcCtD
Cevimeline—Confusional state—Temozolomide—melanoma	0.000459	0.000913	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000459	0.000912	CcSEcCtD
Cevimeline—Oedema—Temozolomide—melanoma	0.000455	0.000905	CcSEcCtD
Cevimeline—Infection—Temozolomide—melanoma	0.000452	0.000899	CcSEcCtD
Cevimeline—Anorexia—Carmustine—melanoma	0.000449	0.000893	CcSEcCtD
Cevimeline—Epistaxis—Docetaxel—melanoma	0.000448	0.00089	CcSEcCtD
Cevimeline—Nervous system disorder—Temozolomide—melanoma	0.000447	0.000888	CcSEcCtD
Cevimeline—Thrombocytopenia—Temozolomide—melanoma	0.000446	0.000886	CcSEcCtD
Cevimeline—Feeling abnormal—Bleomycin—melanoma	0.000445	0.000884	CcSEcCtD
Cevimeline—Agranulocytosis—Docetaxel—melanoma	0.000443	0.000881	CcSEcCtD
Cevimeline—Skin disorder—Temozolomide—melanoma	0.000442	0.000879	CcSEcCtD
Cevimeline—Hypotension—Carmustine—melanoma	0.00044	0.000875	CcSEcCtD
Cevimeline—Hyperhidrosis—Temozolomide—melanoma	0.00044	0.000875	CcSEcCtD
Cevimeline—Decreased appetite—Dactinomycin—melanoma	0.000438	0.00087	CcSEcCtD
Cevimeline—Fatigue—Dactinomycin—melanoma	0.000434	0.000863	CcSEcCtD
Cevimeline—Anorexia—Temozolomide—melanoma	0.000434	0.000863	CcSEcCtD
Cevimeline—Pain—Dactinomycin—melanoma	0.000431	0.000856	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Carmustine—melanoma	0.000429	0.000853	CcSEcCtD
Cevimeline—Urticaria—Bleomycin—melanoma	0.000429	0.000852	CcSEcCtD
Cevimeline—Haemoglobin—Docetaxel—melanoma	0.000429	0.000851	CcSEcCtD
Cevimeline—Rhinitis—Docetaxel—melanoma	0.000427	0.000849	CcSEcCtD
Cevimeline—Body temperature increased—Bleomycin—melanoma	0.000427	0.000848	CcSEcCtD
Cevimeline—Haemorrhage—Docetaxel—melanoma	0.000426	0.000847	CcSEcCtD
Cevimeline—Insomnia—Carmustine—melanoma	0.000426	0.000847	CcSEcCtD
Cevimeline—Hypoaesthesia—Docetaxel—melanoma	0.000424	0.000843	CcSEcCtD
Cevimeline—Paraesthesia—Carmustine—melanoma	0.000423	0.000841	CcSEcCtD
Cevimeline—Pharyngitis—Docetaxel—melanoma	0.000423	0.000841	CcSEcCtD
Cevimeline—Dyspnoea—Carmustine—melanoma	0.00042	0.000835	CcSEcCtD
Cevimeline—Oedema peripheral—Docetaxel—melanoma	0.00042	0.000835	CcSEcCtD
Cevimeline—Somnolence—Carmustine—melanoma	0.000419	0.000833	CcSEcCtD
Cevimeline—Urethral disorder—Docetaxel—melanoma	0.000418	0.00083	CcSEcCtD
Cevimeline—Feeling abnormal—Dactinomycin—melanoma	0.000415	0.000825	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Temozolomide—melanoma	0.000415	0.000825	CcSEcCtD
Cevimeline—Insomnia—Temozolomide—melanoma	0.000412	0.000819	CcSEcCtD
Cevimeline—Gastrointestinal pain—Dactinomycin—melanoma	0.000412	0.000818	CcSEcCtD
Cevimeline—Visual impairment—Docetaxel—melanoma	0.000411	0.000816	CcSEcCtD
Cevimeline—Decreased appetite—Carmustine—melanoma	0.00041	0.000814	CcSEcCtD
Cevimeline—Paraesthesia—Temozolomide—melanoma	0.000409	0.000813	CcSEcCtD
Cevimeline—Dyspnoea—Temozolomide—melanoma	0.000406	0.000807	CcSEcCtD
Cevimeline—Somnolence—Temozolomide—melanoma	0.000405	0.000805	CcSEcCtD
Cevimeline—Pain—Carmustine—melanoma	0.000403	0.000801	CcSEcCtD
Cevimeline—Constipation—Carmustine—melanoma	0.000403	0.000801	CcSEcCtD
Cevimeline—Dyspepsia—Temozolomide—melanoma	0.000401	0.000797	CcSEcCtD
Cevimeline—Eye disorder—Docetaxel—melanoma	0.000398	0.000792	CcSEcCtD
Cevimeline—Abdominal pain—Dactinomycin—melanoma	0.000398	0.000791	CcSEcCtD
Cevimeline—Body temperature increased—Dactinomycin—melanoma	0.000398	0.000791	CcSEcCtD
Cevimeline—Hypersensitivity—Bleomycin—melanoma	0.000398	0.00079	CcSEcCtD
Cevimeline—Decreased appetite—Temozolomide—melanoma	0.000396	0.000787	CcSEcCtD
Cevimeline—Flushing—Docetaxel—melanoma	0.000396	0.000786	CcSEcCtD
Cevimeline—Cardiac disorder—Docetaxel—melanoma	0.000396	0.000786	CcSEcCtD
Cevimeline—Fatigue—Temozolomide—melanoma	0.000393	0.00078	CcSEcCtD
Cevimeline—Constipation—Temozolomide—melanoma	0.000389	0.000774	CcSEcCtD
Cevimeline—Pain—Temozolomide—melanoma	0.000389	0.000774	CcSEcCtD
Cevimeline—Feeling abnormal—Carmustine—melanoma	0.000388	0.000772	CcSEcCtD
Cevimeline—Asthenia—Bleomycin—melanoma	0.000387	0.00077	CcSEcCtD
Cevimeline—Angiopathy—Docetaxel—melanoma	0.000387	0.000769	CcSEcCtD
Cevimeline—Gastrointestinal pain—Carmustine—melanoma	0.000385	0.000766	CcSEcCtD
Cevimeline—Chills—Docetaxel—melanoma	0.000383	0.00076	CcSEcCtD
Cevimeline—Pruritus—Bleomycin—melanoma	0.000382	0.000759	CcSEcCtD
Cevimeline—Arrhythmia—Docetaxel—melanoma	0.000381	0.000757	CcSEcCtD
Cevimeline—Alopecia—Docetaxel—melanoma	0.000377	0.000749	CcSEcCtD
Cevimeline—Feeling abnormal—Temozolomide—melanoma	0.000375	0.000746	CcSEcCtD
Cevimeline—Body temperature increased—Carmustine—melanoma	0.000373	0.00074	CcSEcCtD
Cevimeline—Abdominal pain—Carmustine—melanoma	0.000373	0.00074	CcSEcCtD
Cevimeline—Gastrointestinal pain—Temozolomide—melanoma	0.000372	0.00074	CcSEcCtD
Cevimeline—Malnutrition—Docetaxel—melanoma	0.000371	0.000737	CcSEcCtD
Cevimeline—Hypersensitivity—Dactinomycin—melanoma	0.000371	0.000737	CcSEcCtD
Cevimeline—Dysgeusia—Docetaxel—melanoma	0.000363	0.000722	CcSEcCtD
Cevimeline—Urticaria—Temozolomide—melanoma	0.000362	0.000719	CcSEcCtD
Cevimeline—Asthenia—Dactinomycin—melanoma	0.000361	0.000718	CcSEcCtD
Cevimeline—Abdominal pain—Temozolomide—melanoma	0.00036	0.000715	CcSEcCtD
Cevimeline—Body temperature increased—Temozolomide—melanoma	0.00036	0.000715	CcSEcCtD
Cevimeline—Back pain—Docetaxel—melanoma	0.000359	0.000713	CcSEcCtD
Cevimeline—Muscle spasms—Docetaxel—melanoma	0.000357	0.000709	CcSEcCtD
Cevimeline—Hypersensitivity—Carmustine—melanoma	0.000347	0.00069	CcSEcCtD
Cevimeline—Diarrhoea—Dactinomycin—melanoma	0.000345	0.000685	CcSEcCtD
Cevimeline—Vomiting—Bleomycin—melanoma	0.000343	0.000682	CcSEcCtD
Cevimeline—Anaemia—Docetaxel—melanoma	0.000343	0.000682	CcSEcCtD
Cevimeline—Rash—Bleomycin—melanoma	0.00034	0.000676	CcSEcCtD
Cevimeline—Dermatitis—Bleomycin—melanoma	0.00034	0.000676	CcSEcCtD
Cevimeline—Asthenia—Carmustine—melanoma	0.000338	0.000672	CcSEcCtD
Cevimeline—Hypersensitivity—Temozolomide—melanoma	0.000336	0.000667	CcSEcCtD
Cevimeline—Syncope—Docetaxel—melanoma	0.000333	0.000661	CcSEcCtD
Cevimeline—Leukopenia—Docetaxel—melanoma	0.000332	0.00066	CcSEcCtD
Cevimeline—Palpitations—Docetaxel—melanoma	0.000328	0.000652	CcSEcCtD
Cevimeline—Asthenia—Temozolomide—melanoma	0.000327	0.000649	CcSEcCtD
Cevimeline—Loss of consciousness—Docetaxel—melanoma	0.000326	0.000648	CcSEcCtD
Cevimeline—Cough—Docetaxel—melanoma	0.000324	0.000644	CcSEcCtD
Cevimeline—Diarrhoea—Carmustine—melanoma	0.000322	0.000641	CcSEcCtD
Cevimeline—Pruritus—Temozolomide—melanoma	0.000322	0.00064	CcSEcCtD
Cevimeline—Convulsion—Docetaxel—melanoma	0.000322	0.000639	CcSEcCtD
Cevimeline—Nausea—Bleomycin—melanoma	0.000321	0.000637	CcSEcCtD
Cevimeline—Hypertension—Docetaxel—melanoma	0.00032	0.000637	CcSEcCtD
Cevimeline—Vomiting—Dactinomycin—melanoma	0.00032	0.000636	CcSEcCtD
Cevimeline—Rash—Dactinomycin—melanoma	0.000318	0.000631	CcSEcCtD
Cevimeline—Chest pain—Docetaxel—melanoma	0.000316	0.000628	CcSEcCtD
Cevimeline—Arthralgia—Docetaxel—melanoma	0.000316	0.000628	CcSEcCtD
Cevimeline—Myalgia—Docetaxel—melanoma	0.000316	0.000628	CcSEcCtD
Cevimeline—Dizziness—Carmustine—melanoma	0.000312	0.000619	CcSEcCtD
Cevimeline—Diarrhoea—Temozolomide—melanoma	0.000312	0.000619	CcSEcCtD
Cevimeline—Confusional state—Docetaxel—melanoma	0.000305	0.000607	CcSEcCtD
Cevimeline—Oedema—Docetaxel—melanoma	0.000303	0.000602	CcSEcCtD
Cevimeline—Dizziness—Temozolomide—melanoma	0.000301	0.000598	CcSEcCtD
Cevimeline—Infection—Docetaxel—melanoma	0.000301	0.000598	CcSEcCtD
Cevimeline—Vomiting—Carmustine—melanoma	0.0003	0.000595	CcSEcCtD
Cevimeline—Nausea—Dactinomycin—melanoma	0.000299	0.000594	CcSEcCtD
Cevimeline—Shock—Docetaxel—melanoma	0.000298	0.000592	CcSEcCtD
Cevimeline—Rash—Carmustine—melanoma	0.000297	0.00059	CcSEcCtD
Cevimeline—Nervous system disorder—Docetaxel—melanoma	0.000297	0.00059	CcSEcCtD
Cevimeline—Dermatitis—Carmustine—melanoma	0.000297	0.00059	CcSEcCtD
Cevimeline—Thrombocytopenia—Docetaxel—melanoma	0.000297	0.000589	CcSEcCtD
Cevimeline—Tachycardia—Docetaxel—melanoma	0.000296	0.000587	CcSEcCtD
Cevimeline—Headache—Carmustine—melanoma	0.000295	0.000587	CcSEcCtD
Cevimeline—Skin disorder—Docetaxel—melanoma	0.000294	0.000585	CcSEcCtD
Cevimeline—Vomiting—Temozolomide—melanoma	0.00029	0.000575	CcSEcCtD
Cevimeline—Anorexia—Docetaxel—melanoma	0.000289	0.000574	CcSEcCtD
Cevimeline—Rash—Temozolomide—melanoma	0.000287	0.000571	CcSEcCtD
Cevimeline—Dermatitis—Temozolomide—melanoma	0.000287	0.00057	CcSEcCtD
Cevimeline—Headache—Temozolomide—melanoma	0.000285	0.000567	CcSEcCtD
Cevimeline—Hypotension—Docetaxel—melanoma	0.000283	0.000562	CcSEcCtD
Cevimeline—Nausea—Carmustine—melanoma	0.00028	0.000556	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Docetaxel—melanoma	0.000276	0.000548	CcSEcCtD
Cevimeline—Insomnia—Docetaxel—melanoma	0.000274	0.000544	CcSEcCtD
Cevimeline—Paraesthesia—Docetaxel—melanoma	0.000272	0.00054	CcSEcCtD
Cevimeline—Nausea—Temozolomide—melanoma	0.000271	0.000538	CcSEcCtD
Cevimeline—Dyspnoea—Docetaxel—melanoma	0.00027	0.000537	CcSEcCtD
Cevimeline—Somnolence—Docetaxel—melanoma	0.000269	0.000535	CcSEcCtD
Cevimeline—Dyspepsia—Docetaxel—melanoma	0.000267	0.00053	CcSEcCtD
Cevimeline—Decreased appetite—Docetaxel—melanoma	0.000263	0.000523	CcSEcCtD
Cevimeline—Fatigue—Docetaxel—melanoma	0.000261	0.000519	CcSEcCtD
Cevimeline—Pain—Docetaxel—melanoma	0.000259	0.000515	CcSEcCtD
Cevimeline—Constipation—Docetaxel—melanoma	0.000259	0.000515	CcSEcCtD
Cevimeline—Feeling abnormal—Docetaxel—melanoma	0.00025	0.000496	CcSEcCtD
Cevimeline—Gastrointestinal pain—Docetaxel—melanoma	0.000248	0.000492	CcSEcCtD
Cevimeline—Body temperature increased—Docetaxel—melanoma	0.000239	0.000476	CcSEcCtD
Cevimeline—Abdominal pain—Docetaxel—melanoma	0.000239	0.000476	CcSEcCtD
Cevimeline—Hypersensitivity—Docetaxel—melanoma	0.000223	0.000443	CcSEcCtD
Cevimeline—Asthenia—Docetaxel—melanoma	0.000217	0.000432	CcSEcCtD
Cevimeline—Pruritus—Docetaxel—melanoma	0.000214	0.000426	CcSEcCtD
Cevimeline—Diarrhoea—Docetaxel—melanoma	0.000207	0.000412	CcSEcCtD
Cevimeline—Dizziness—Docetaxel—melanoma	0.0002	0.000398	CcSEcCtD
Cevimeline—Vomiting—Docetaxel—melanoma	0.000193	0.000383	CcSEcCtD
Cevimeline—Rash—Docetaxel—melanoma	0.000191	0.000379	CcSEcCtD
Cevimeline—Dermatitis—Docetaxel—melanoma	0.000191	0.000379	CcSEcCtD
Cevimeline—Headache—Docetaxel—melanoma	0.00019	0.000377	CcSEcCtD
Cevimeline—Nausea—Docetaxel—melanoma	0.00018	0.000357	CcSEcCtD
Cevimeline—CHRM1—Signaling Pathways—EDNRB—melanoma	2.93e-05	0.000337	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—RAC1—melanoma	2.92e-05	0.000336	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—EDNRB—melanoma	2.92e-05	0.000336	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PLCB4—melanoma	2.89e-05	0.000332	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PTK2B—melanoma	2.85e-05	0.000327	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PTK2B—melanoma	2.84e-05	0.000326	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—GNA11—melanoma	2.77e-05	0.000318	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—GAB2—melanoma	2.77e-05	0.000318	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—GAB2—melanoma	2.76e-05	0.000317	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—GNA11—melanoma	2.76e-05	0.000317	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PLA2G6—melanoma	2.76e-05	0.000317	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—FLT1—melanoma	2.76e-05	0.000317	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—FLT1—melanoma	2.75e-05	0.000316	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—PIK3CG—melanoma	2.73e-05	0.000314	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—PIK3CG—melanoma	2.72e-05	0.000313	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—SLC6A11—melanoma	2.72e-05	0.000312	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PIP4K2A—melanoma	2.72e-05	0.000312	CbGpPWpGaD
Cevimeline—FMO1—Metabolism—AKT1—melanoma	2.68e-05	0.000308	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—MTAP—melanoma	2.64e-05	0.000304	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CXCR4—melanoma	2.6e-05	0.000299	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HDAC2—melanoma	2.6e-05	0.000299	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—FOXO4—melanoma	2.6e-05	0.000299	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HDAC2—melanoma	2.59e-05	0.000298	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—FOXO4—melanoma	2.59e-05	0.000298	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CXCR4—melanoma	2.59e-05	0.000298	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—GNAQ—melanoma	2.57e-05	0.000296	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—GNAQ—melanoma	2.57e-05	0.000295	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—PIK3CG—melanoma	2.48e-05	0.000285	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—VCAN—melanoma	2.48e-05	0.000285	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PIK3CG—melanoma	2.47e-05	0.000284	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—ABCB1—melanoma	2.42e-05	0.000279	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—SYK—melanoma	2.42e-05	0.000278	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—SYK—melanoma	2.41e-05	0.000277	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—PIK3CD—melanoma	2.4e-05	0.000276	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—PIK3CD—melanoma	2.39e-05	0.000275	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NGFR—melanoma	2.37e-05	0.000273	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—AKT3—melanoma	2.37e-05	0.000273	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ITGAV—melanoma	2.37e-05	0.000273	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ITGAV—melanoma	2.37e-05	0.000272	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—AKT3—melanoma	2.37e-05	0.000272	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NGFR—melanoma	2.37e-05	0.000272	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—LUM—melanoma	2.35e-05	0.000271	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PHGDH—melanoma	2.35e-05	0.000271	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—HPSE—melanoma	2.31e-05	0.000266	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CUBN—melanoma	2.27e-05	0.000261	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PRKCA—melanoma	2.23e-05	0.000256	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—ERCC2—melanoma	2.21e-05	0.000254	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—SOCS1—melanoma	2.2e-05	0.000253	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—MAP2K1—melanoma	2.19e-05	0.000252	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—S100B—melanoma	2.19e-05	0.000252	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—SOCS1—melanoma	2.19e-05	0.000252	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—SDHD—melanoma	2.19e-05	0.000252	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CSPG4—melanoma	2.19e-05	0.000252	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—BSG—melanoma	2.19e-05	0.000252	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—MAP2K1—melanoma	2.19e-05	0.000251	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—S100B—melanoma	2.19e-05	0.000251	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—PIK3CD—melanoma	2.18e-05	0.000251	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PIK3CD—melanoma	2.17e-05	0.00025	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GPAM—melanoma	2.12e-05	0.000244	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ERBB4—melanoma	2.1e-05	0.000241	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—PIK3CB—melanoma	2.09e-05	0.000241	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ERBB4—melanoma	2.09e-05	0.00024	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CYP17A1—melanoma	2.09e-05	0.00024	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—PIK3CB—melanoma	2.09e-05	0.00024	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CDKN2B—melanoma	2.08e-05	0.000239	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CDKN2B—melanoma	2.07e-05	0.000238	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CD86—melanoma	2.01e-05	0.000231	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—CXCL8—melanoma	2.01e-05	0.000231	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CD86—melanoma	2e-05	0.000231	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—CXCL8—melanoma	2e-05	0.00023	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—EDN1—melanoma	2e-05	0.000229	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—EDN1—melanoma	1.99e-05	0.000229	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GNA11—melanoma	1.97e-05	0.000227	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—FGF1—melanoma	1.95e-05	0.000224	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CSF2—melanoma	1.95e-05	0.000224	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CSF2—melanoma	1.94e-05	0.000224	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—FGF1—melanoma	1.94e-05	0.000224	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—FASN—melanoma	1.93e-05	0.000222	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—IL2—melanoma	1.92e-05	0.000221	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—IL2—melanoma	1.91e-05	0.00022	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—E2F1—melanoma	1.91e-05	0.000219	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—E2F1—melanoma	1.9e-05	0.000219	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—PIK3CB—melanoma	1.9e-05	0.000218	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—SLC5A5—melanoma	1.9e-05	0.000218	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PIK3CB—melanoma	1.89e-05	0.000218	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PDGFRA—melanoma	1.89e-05	0.000217	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PDGFRA—melanoma	1.88e-05	0.000217	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PRKCA—melanoma	1.87e-05	0.000215	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ITGB3—melanoma	1.87e-05	0.000215	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ITGB3—melanoma	1.86e-05	0.000214	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PRKCA—melanoma	1.86e-05	0.000214	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CD44—melanoma	1.83e-05	0.000211	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GNAQ—melanoma	1.83e-05	0.000211	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—SPP1—melanoma	1.83e-05	0.000211	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MAP2K2—melanoma	1.83e-05	0.00021	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—SPP1—melanoma	1.83e-05	0.00021	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—CXCL8—melanoma	1.83e-05	0.00021	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MAP2K2—melanoma	1.82e-05	0.00021	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—CXCL8—melanoma	1.82e-05	0.000209	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PLA2G6—melanoma	1.8e-05	0.000207	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CYP1B1—melanoma	1.76e-05	0.000202	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PIK3CG—melanoma	1.75e-05	0.000201	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—IL2—melanoma	1.74e-05	0.000201	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—IL2—melanoma	1.74e-05	0.0002	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TERT—melanoma	1.74e-05	0.0002	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—RAC1—melanoma	1.73e-05	0.000199	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TERT—melanoma	1.73e-05	0.000199	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—RAC1—melanoma	1.73e-05	0.000199	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PPARG—melanoma	1.68e-05	0.000194	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HIF1A—melanoma	1.66e-05	0.000191	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HIF1A—melanoma	1.66e-05	0.000191	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—VCAN—melanoma	1.62e-05	0.000186	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—KDR—melanoma	1.59e-05	0.000183	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—KDR—melanoma	1.58e-05	0.000182	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PIK3CD—melanoma	1.53e-05	0.000177	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—FN1—melanoma	1.53e-05	0.000176	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—FN1—melanoma	1.53e-05	0.000175	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—ALB—melanoma	1.52e-05	0.000174	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NOTCH1—melanoma	1.5e-05	0.000172	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NOTCH1—melanoma	1.49e-05	0.000172	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CD80—melanoma	1.47e-05	0.000169	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PIK3CG—melanoma	1.46e-05	0.000168	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—APC—melanoma	1.46e-05	0.000168	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—KIT—melanoma	1.46e-05	0.000168	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—NRAS—melanoma	1.46e-05	0.000168	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CD80—melanoma	1.46e-05	0.000168	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—KIT—melanoma	1.46e-05	0.000168	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—APC—melanoma	1.46e-05	0.000168	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PIK3CG—melanoma	1.46e-05	0.000168	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—NRAS—melanoma	1.46e-05	0.000168	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ABCB1—melanoma	1.45e-05	0.000167	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—EGF—melanoma	1.45e-05	0.000166	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—EGF—melanoma	1.44e-05	0.000166	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—MAPK3—melanoma	1.4e-05	0.000161	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—MAPK3—melanoma	1.4e-05	0.000161	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—BRAF—melanoma	1.38e-05	0.000158	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—BRAF—melanoma	1.37e-05	0.000158	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CYP17A1—melanoma	1.37e-05	0.000157	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IGF1—melanoma	1.34e-05	0.000154	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PIK3CB—melanoma	1.34e-05	0.000154	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IGF1—melanoma	1.34e-05	0.000154	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—MAPK1—melanoma	1.33e-05	0.000153	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—EGFR—melanoma	1.33e-05	0.000153	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PRKCA—melanoma	1.33e-05	0.000153	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—MAPK1—melanoma	1.33e-05	0.000153	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—EGFR—melanoma	1.33e-05	0.000153	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PTGS2—melanoma	1.33e-05	0.000152	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ERCC2—melanoma	1.32e-05	0.000152	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MAP2K1—melanoma	1.3e-05	0.000149	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MAP2K1—melanoma	1.29e-05	0.000149	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GNA11—melanoma	1.29e-05	0.000148	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PIK3CD—melanoma	1.29e-05	0.000148	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PIK3CD—melanoma	1.28e-05	0.000148	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—PIK3CA—melanoma	1.28e-05	0.000147	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—PIK3CA—melanoma	1.27e-05	0.000146	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—FASN—melanoma	1.26e-05	0.000145	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—KRAS—melanoma	1.26e-05	0.000145	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—KRAS—melanoma	1.26e-05	0.000144	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—SLC5A5—melanoma	1.24e-05	0.000143	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—FGF2—melanoma	1.23e-05	0.000142	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—FGF2—melanoma	1.23e-05	0.000141	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GNAQ—melanoma	1.2e-05	0.000138	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CD44—melanoma	1.2e-05	0.000138	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—PIK3CA—melanoma	1.16e-05	0.000133	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PTEN—melanoma	1.16e-05	0.000133	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PIK3CA—melanoma	1.15e-05	0.000133	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MDM2—melanoma	1.15e-05	0.000133	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CYP1B1—melanoma	1.15e-05	0.000132	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MDM2—melanoma	1.15e-05	0.000132	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ERBB2—melanoma	1.14e-05	0.000131	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ERBB2—melanoma	1.13e-05	0.00013	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PIK3CB—melanoma	1.12e-05	0.000129	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PIK3CB—melanoma	1.12e-05	0.000129	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CXCL8—melanoma	1.08e-05	0.000124	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CXCL8—melanoma	1.07e-05	0.000124	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—HRAS—melanoma	1.07e-05	0.000123	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—HRAS—melanoma	1.07e-05	0.000123	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CDKN1B—melanoma	1.05e-05	0.000121	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CDKN1B—melanoma	1.05e-05	0.000121	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PIK3CG—melanoma	1.04e-05	0.00012	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—AKT1—melanoma	1.04e-05	0.00012	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—AKT1—melanoma	1.04e-05	0.000119	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CASP3—melanoma	1.03e-05	0.000119	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IL2—melanoma	1.03e-05	0.000119	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CASP3—melanoma	1.03e-05	0.000118	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IL2—melanoma	1.03e-05	0.000118	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—IL6—melanoma	1.03e-05	0.000118	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—IL6—melanoma	1.02e-05	0.000118	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PPARG—melanoma	1.01e-05	0.000116	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CCND1—melanoma	1e-05	0.000116	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CCND1—melanoma	1e-05	0.000115	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CTNNB1—melanoma	9.95e-06	0.000114	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CTNNB1—melanoma	9.92e-06	0.000114	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MMP9—melanoma	9.75e-06	0.000112	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MMP9—melanoma	9.72e-06	0.000112	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CDKN1A—melanoma	9.72e-06	0.000112	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PTEN—melanoma	9.7e-06	0.000112	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CDKN1A—melanoma	9.69e-06	0.000111	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PTEN—melanoma	9.67e-06	0.000111	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NFKB1—melanoma	9.65e-06	0.000111	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NFKB1—melanoma	9.62e-06	0.000111	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ABCB1—melanoma	9.47e-06	0.000109	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—AKT1—melanoma	9.46e-06	0.000109	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—AKT1—melanoma	9.43e-06	0.000108	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PIK3CD—melanoma	9.18e-06	0.000106	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ALB—melanoma	9.06e-06	0.000104	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—VEGFA—melanoma	8.76e-06	0.000101	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—VEGFA—melanoma	8.73e-06	0.0001	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PRKCA—melanoma	8.71e-06	0.0001	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—STAT3—melanoma	8.67e-06	9.97e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NRAS—melanoma	8.65e-06	9.95e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—STAT3—melanoma	8.64e-06	9.94e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ERCC2—melanoma	8.64e-06	9.94e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NRAS—melanoma	8.62e-06	9.92e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MAPK3—melanoma	8.29e-06	9.53e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MAPK3—melanoma	8.26e-06	9.5e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PIK3CA—melanoma	8.15e-06	9.38e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MYC—melanoma	8.06e-06	9.27e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MYC—melanoma	8.03e-06	9.24e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PIK3CB—melanoma	8e-06	9.2e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PTGS2—melanoma	7.93e-06	9.11e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MAPK1—melanoma	7.88e-06	9.07e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—EGFR—melanoma	7.88e-06	9.06e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MAPK1—melanoma	7.86e-06	9.04e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—EGFR—melanoma	7.86e-06	9.04e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—KRAS—melanoma	7.45e-06	8.56e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—KRAS—melanoma	7.42e-06	8.54e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PTEN—melanoma	6.91e-06	7.95e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PIK3CA—melanoma	6.84e-06	7.87e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PIK3CG—melanoma	6.82e-06	7.85e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PIK3CA—melanoma	6.82e-06	7.84e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—AKT1—melanoma	6.66e-06	7.66e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TP53—melanoma	6.62e-06	7.61e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TP53—melanoma	6.6e-06	7.59e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PPARG—melanoma	6.59e-06	7.58e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HRAS—melanoma	6.33e-06	7.28e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HRAS—melanoma	6.31e-06	7.26e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IL6—melanoma	6.06e-06	6.97e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IL6—melanoma	6.04e-06	6.94e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PIK3CD—melanoma	6e-06	6.9e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ALB—melanoma	5.92e-06	6.81e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—AKT1—melanoma	5.59e-06	6.43e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—AKT1—melanoma	5.57e-06	6.41e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PIK3CB—melanoma	5.23e-06	6.01e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PTGS2—melanoma	5.18e-06	5.96e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PIK3CA—melanoma	4.88e-06	5.61e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PTEN—melanoma	4.52e-06	5.2e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—AKT1—melanoma	3.98e-06	4.58e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PIK3CA—melanoma	3.19e-06	3.67e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—AKT1—melanoma	2.6e-06	3e-05	CbGpPWpGaD
